CLPTClearPoint Neuro, Inc.

$340M

FY 2024 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$31M+31.0% YoY

Gross Profit

$19M60.9% margin

Operating Income

-$20M-62.9% margin

Net Income

-$19M-60.3% margin

EPS (Diluted)

$-0.70

Cash Flow

Operating Cash Flow

-$9M

Free Cash Flow

-$9M

Stock-Based Comp.

$7M

Balance Sheet

Total Assets

$39M

Total Liabilities

$14M

Stockholders' Equity

$25M

Cash & Equivalents

$20M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$31M	$24M	+31.0%
Gross Profit	$19M	$14M	+40.5%
Operating Income	-$20M	-$22M	+12.0%
Net Income	-$19M	-$22M	+14.4%

CLPT FY 2024 Earnings — ClearPoint Neuro, Inc. Revenue & Financial Results | Market Cap Arena